Conditions: Chronic Obstructive Pulmonary Disease Lung Disease
Keywords: Respiratory disease Chronic Obstructive Pulmonary Disease
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 63
Healthy volunteers: no

Brief summary:
The purpose of the study is to investigate the tolerability and safety of AZD2423 in Patients with chronic obstructive pulmonary disease.

Detailed description:

Arms:
arm 1: AZD2423 Oral Treatment for 28 days arm 2: Oral treatment for 28 days

Interventions: intervention 1: AZD2423 intervention 2: Placebo to AZD2423
Intervention descriptions: intervention 1: 100 mg oral treatment once daily for 28 days intervention 2: Oral treatment once daily for 28 days

Protocol document: